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Endovascular repair of aortic aneurysms
(EVAR) using standard stent-grafts is well
established as an alternative to conventional
surgery in light of the extensive evidence.
However, there are many patients in whom
standard stent-grafts are not applicable due
to anatomical constraints. A number of
advanced endograft technologies have been
developed to extend the use of EVAR in
circumstances of unfavorable anatomy, in-
cluding:
1) Stent-graft configurations that extend
across and preserve the iliac bifurcation;
2) Fenestrated stent-graft repair of abdom-
inal aortic aneurysms;
3) Endovascular repair of aortic aneurysms
using side branches to preserve perfu-
sion of abdominal aortic branches;
4) Endovascular repair combined with de-
branching of the abdominal aorta and
extra-anatomical bypass;
5) Side-branched and fenestrated stent-
grafts (including in situ fenestrations) to
preserve flow through the branches of
the aortic arch; and
6) Stent-graft repair combined with de-
branching of the aortic arch and extra-
anatomical bypass.
The feasibility of all of these techniques has
been established, and as a few centers have
begun to accumulate clinical experience,1–9
it can be anticipated that many more will
adopt these techniques in the near future. As
in the early days of EVAR, however, enthusi-
asm and optimism for these techniques
needs to be tempered by recognition of
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potential risks, the extent of which is largely
unknown.
Methodical and rigorous evaluation of
various aspects of these advanced techniques
is necessary in order to (1) evaluate their
efficacy in relation to the primary clinical
objectives, (2) identify and define complica-
tions unique to the advanced techniques, (3)
identify the potential effects of stent-graft
modifications upon stent-graft function, and
(4) study complications further to identify
solutions. This information is essential before
the techniques can be advocated for day-to-
day clinical practice. However, there are
a number of hurdles to developing such
evidence.
The biggest hurdle arises from the fact that,
in the early stages of development, new
technologies can be applied to a relatively
small number of patients in each of the
centers using them, and it takes a long time
to establish a substantial cohort, even in the
busiest of centers. In several ways, the issues
facing further evaluation and development
of these techniques today are the same as
those facing standard EVAR a decade ago.
An effective response to this situation was
the EUROSTAR registry, a collaborative pro-
ject.
The EUROSTAR project has played an
important role over the last decade in the
evaluation of almost every aspect of standard
EVAR. EUROSTAR analyses also provided the
clinical information that was needed to iden-
tify the basic requirements for durable en-
dovascular exclusion of an aneurysm. These
data had a significant impact on the evolution
of stent-graft design into more effective later
iterations.
There is once again a strong case for
physicians practicing these techniques to
create a joint venture of clinical research. A
collective project focusing on advanced tech-
niques is necessary to develop a database
that is large enough to allow conclusions to
be drawn within a timeframe that will support
efficient development and evaluation of these
techniques. It is the aim of the Global
Collaborators on Advanced Stent-Graft Tech-
niques for Aneurysm Repair (GLOBALSTAR)
project to serve this role.
STANDARD THORACIC EVAR
Treatment of thoracic aortic pathology using
standard stent-graft techniques has been in
clinical practice for longer than a decade.
There has been a perception that the benefits
of EVAR in the thoracic segment considerably
outweigh those of conventional surgery,
which involves thoracotomy and, often, ex-
tracorporeal bypass. Advances in this area,
however, have been slow to come due to
a number of factors. The incidence of thoracic
disease is lower compared to abdominal
aneurysms, which prolonged the learning
curve and slowed turnaround of the technol-
ogy cycle. The majority of the published
studies included a variety of aortic patholo-
gies treated using various stent-graft itera-
tions, making it somewhat difficult to define
the role of EVAR in each type of pathology.
Much of the refinement of the concepts of
thoracic EVAR has been extrapolated from
the infrarenal aneurysm experience. Howev-
er, this approach has limitations due to
differences in the abdominal and thoracic
aortic environment. For these reasons, it is
essential to continue further evaluation of
standard thoracic EVAR, in addition to the
aforementioned advanced techniques, with
stratified analyses according to the type of
pathology treated.
PROS AND CONS OF
REGISTRY-BASED RESEARCH INTO
STENT-GRAFT TECHNIQUES
Registry-based studies have been playing
a major role in vascular research over the
last decade, and the value of the information
generated in this way is understood clearly.
Registry data are recognized to represent
pragmatic results that are achieved in ‘‘real
life,’’ and they allow us to follow the evolution
of techniques over time. On the other hand,
data from controlled clinical trials reflect
results during a specified period of time from
patients and centers that have gone through
a different type and level of selection pro-
cesses. The latter data serve specific pur-
poses, and quite often there is no alternative
method of collecting such information, e.g.,
comparison of two different techniques.
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Whether such results can be generalized
remains questionable because they rarely
reflect everyday practice. Mandatory regis-
tries are becoming a feature of clinical
practice in strongly regulated countries, when
the purpose is to determine standards and to
provide a benchmark for comparative audit.
Observational data are a necessary prerequi-
site for planning of randomized clinical trials.
Some advanced endovascular technologies
have applications that are unlikely ever to be
subjected to randomized clinical trials despite
uncertainties regarding the overall perfor-
mance of such techniques. There are a number
of reasons for this, e.g., the lack of widespread
application of such techniques, making it
difficult to sustain randomized trials; a lack
of equipoise in relation to certain subsets of
patients or certain techniques; variance of
opinion among physicians as to the circum-
stances that should create equipoise in the
choice of treatment, particularly when the
alternative treatment modality is conservative
management or a much higher risk operation,
etc. For all these reasons, a dedicated registry
is essential for the evaluation of advanced
stent-graft techniques.
Registries, particularly voluntary registries,
do have drawbacks: absence of data monitor-
ing, drop-off in follow-up data registration,
absence of a core laboratory, and heteroge-
neity of factors relating to patients, physi-
cians, and technical aspects, to name a few.
However, lessons have been learned in
running large registries, e.g., in the areas of
securing funding, maintaining collaborator
satisfaction, encouraging proactive scientific
participation from collaborators, achieving
expeditious dissemination of information,
etc. The GLOBALSTAR project will benefit
from this experience to enable it to overcome
or mitigate these limitations.
GLOBALSTAR
Intended Purposes
¤Create follow-up protocols for each of the
advanced techniques;
¤Standardize investigations that are part of
follow-up protocols;
¤Set reporting standards for advanced tech-
niques and compile definitions and lists of
potential complications associated with
these techniques;
¤Evaluate the techniques in terms of prima-
ry and non-primary endpoints;
¤Establish an archive of all preoperative and
follow-up imaging;
¤Develop a core laboratory for image eval-
uation to aid identification of mechanisms
of function and failure;
¤Provide an early warning system of com-
plications specific to advanced techniques;
and
¤Develop a method of evaluating the tech-
niques when used in emergency situa-
tions.
Organization, Data Collection,
and Analyses
The GLOBALSTAR project is organized as
a network of physicians with established or
developing experience of advanced EVAR
techniques. Collaborators are expected to
propose and lead specific studies. An In-
ternational Advisory Board will discharge
the following responsibilities: (1) proposing
or approving registry protocols; (2) oversee-
ing data collection, data protection, and
ethical responsibilities; (3) developing and
verifying reports and publications; (4) ensur-
ing freedom from conflict of interest and bias
and overseeing financial arrangements; and
finally (5) approving applications from new
participating centers. The project will also be
supported by registry advisors, a data man-
ger, and a health scientist. The principal
investigator will take responsibility for the
day-to-day functioning of the registry under
the supervision of the International Advisory
Board.
Performed at the time of enrollment, the
consenting process involves informing the
patients of the purposes of the registry and
the manner in which the data will be treated.
For reasons of confidentiality, the data regis-
try needs to be absolutely secure. In order to
best serve the purposes of the participating
collaborators, it should also be convenient
and easy to use, with minimal impact upon
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local resources. To fit these requirements, the
registry will be Internet-based, incorporating
security features equivalent to those of finan-
cial transactions. (The technical details of the
Internet security setup will be available for
inspection on specific enquiry.) Using secure
access, authorized individuals will be able to
input data via the Internet directly; they will
also be able to freely view all data accumu-
lated from their particular center at any time
and download it into various popular soft-
ware packages (e.g., SPSS, Microsoft Excel).
This could serve the purpose of a secure
database for each center and may be used for
their clinical and academic purposes in an
appropriate manner. Patients must be regis-
tered before treatment to reduce reporting
bias influenced by outcomes. The entire
registry data will be included in periodic
analyses and for specific studies.
Core Laboratory
The increasing complexity of stent-graft
design calls for increasing attention to detail
in their further evaluation. Understanding the
mechanisms of stent-graft failure often in-
volves careful analysis of computed tomo-
graphic (CT) images using a robust and
consistent methodology. The importance of
a dedicated core laboratory to perform this
function is particularly great in relation to
advanced EVAR techniques since minor
changes in stent-graft configuration, struc-
ture, or position have the potential to initiate
significant clinical complications, e.g., target
vessel loss after fenestrated EVAR. Resolution
of routine CT scans in the majority of the
centers will be adequate for the purposes of
the core laboratory, whose database will also
use an Internet-based system of data collec-
tion. Once uploaded to the registry, patient
details from the imaging files will be replaced
with case-record identifiers so that images
can be stored anonymously, while preserving
the ability to link them with corresponding
clinical data when required.
Relationship With Industry
Commercial manufacturers of stent-grafts
and related technologies stand to benefit
from scientific evaluation of advanced EVAR
techniques, without which it would not be
possible to improve these techniques or to
define their role in disease management. The
registry will foster a mutually beneficial
partnership between physicians and industry
representatives who will be consulted on the
evolution and strategic planning of the pro-
gram. There will be opportunities for industry
partners to be granted access to registry data
by agreement, provided confidentiality of
contributing physicians and patients is pre-
served.
It is one of the functions of the International
Advisory Board to ensure transparency of
registry function and freedom from bias or
adverse influence from individual companies
or from the industry as a whole, so that the
credibility of the data published will not be
undermined.
FUTURE DIRECTIONS
The overall aim of the GLOBALSTAR project
is to make an important contribution to the
continuing evolution of EVAR technologies
and to ensure maximal benefit for patients
with aneurysm disease. Success will depend
upon the enthusiastic and committed support
of physicians and industrial partners around
the world.
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